HealthEquity (NASDAQ:HQY) Given New $120.00 Price Target at Raymond James

HealthEquity (NASDAQ:HQY) had its price target lifted by stock analysts at Raymond James from $105.00 to $120.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Raymond James’ target price indicates a potential upside of 15.90% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. Royal Bank of Canada boosted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company. Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Finally, Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $112.38.

HealthEquity Price Performance

HQY stock traded down $5.89 during midday trading on Tuesday, reaching $103.54. The company had a trading volume of 368,321 shares, compared to its average volume of 715,711. The company has a market capitalization of $8.97 billion, a price-to-earnings ratio of 94.92, a price-to-earnings-growth ratio of 1.60 and a beta of 0.55. The stock has a 50 day moving average price of $103.98 and a 200-day moving average price of $92.64. HealthEquity has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the company posted $0.40 EPS. Equities research analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,000 shares of company stock valued at $3,895,788. 2.20% of the stock is owned by corporate insiders.

Institutional Trading of HealthEquity

Hedge funds and other institutional investors have recently bought and sold shares of the company. Creative Planning raised its holdings in shares of HealthEquity by 18.6% during the third quarter. Creative Planning now owns 23,632 shares of the company’s stock valued at $1,934,000 after acquiring an additional 3,706 shares in the last quarter. Private Advisor Group LLC purchased a new stake in shares of HealthEquity in the third quarter worth $208,000. Wealth Enhancement Advisory Services LLC grew its stake in shares of HealthEquity by 18.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company’s stock worth $299,000 after acquiring an additional 578 shares during the last quarter. State of Alaska Department of Revenue grew its stake in shares of HealthEquity by 7.2% in the third quarter. State of Alaska Department of Revenue now owns 10,146 shares of the company’s stock worth $830,000 after acquiring an additional 685 shares during the last quarter. Finally, Nisa Investment Advisors LLC grew its stake in shares of HealthEquity by 19.8% in the third quarter. Nisa Investment Advisors LLC now owns 3,420 shares of the company’s stock worth $280,000 after acquiring an additional 566 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.